WallStSmart

Seagate Technology PLC (STX)vsStryker Corporation (SYK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Stryker Corporation generates 130% more annual revenue ($25.27B vs $11.01B). STX leads profitability with a 21.6% profit margin vs 13.2%. STX appears more attractively valued with a PEG of 0.71. STX earns a higher WallStSmart Score of 77/100 (B+).

STX

Strong Buy

77

out of 100

Grade: B+

Growth: 7.3Profit: 9.5Value: 5.0Quality: 4.0
Piotroski: 6/9Altman Z: 0.62

SYK

Buy

57

out of 100

Grade: C

Growth: 6.0Profit: 6.5Value: 4.0Quality: 6.5
Piotroski: 3/9Altman Z: 2.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for STX.

SYKSignificantly Overvalued (-39.3%)

Margin of Safety

-39.3%

Fair Value

$223.02

Current Price

$305.66

$82.64 premium

UndervaluedFair: $223.02Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

STX6 strengths · Avg: 9.8/10
Market CapQuality
$230.51B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
217.2%10/10

Every $100 of equity generates 217 in profit

Operating MarginProfitability
35.7%10/10

Strong operational efficiency at 35.7%

Revenue GrowthGrowth
44.1%10/10

Revenue surging 44.1% year-over-year

EPS GrowthGrowth
108.3%10/10

Earnings expanding 108.3% YoY

Profit MarginProfitability
21.6%9/10

Keeps 22 of every $100 in revenue as profit

SYK1 strengths · Avg: 9.0/10
Market CapQuality
$119.69B9/10

Large-cap with strong market position

Areas to Watch

STX4 concerns · Avg: 1.8/10
P/E RatioValuation
97.1x2/10

Premium valuation, high expectations priced in

Price/BookValuation
189.8x2/10

Trading at 189.8x book value

Altman Z-ScoreHealth
0.622/10

Distress zone — elevated risk

Debt/EquityHealth
3.821/10

Elevated debt levels

SYK3 concerns · Avg: 3.7/10
P/E RatioValuation
36.1x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : STX

The strongest argument for STX centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 21.6% and operating margin at 35.7%. Revenue growth of 44.1% demonstrates continued momentum.

Bull Case : SYK

The strongest argument for SYK centers on Market Cap. PEG of 1.47 suggests the stock is reasonably priced for its growth.

Bear Case : STX

The primary concerns for STX are P/E Ratio, Price/Book, Altman Z-Score. A P/E of 97.1x leaves little room for execution misses. Debt-to-equity of 3.82 is elevated, increasing financial risk.

Bear Case : SYK

The primary concerns for SYK are P/E Ratio, Revenue Growth, Piotroski F-Score.

Key Dynamics to Monitor

STX profiles as a growth stock while SYK is a value play — different risk/reward profiles.

STX carries more volatility with a beta of 2.08 — expect wider price swings.

STX is growing revenue faster at 44.1% — sustainability is the question.

STX generates stronger free cash flow (953M), providing more financial flexibility.

Bottom Line

STX scores higher overall (77/100 vs 57/100), backed by strong 21.6% margins and 44.1% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Seagate Technology PLC

TECHNOLOGY · COMPUTER HARDWARE · USA

Seagate Technology Holdings plc, an Irish public limited company (commonly referred to as Seagate) is an American data storage company.

Stryker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

Visit Website →

Want to dig deeper into these stocks?